726 related articles for article (PubMed ID: 28232614)
1. Preclinical Evaluation of
Declercq L; Rombouts F; Koole M; Fierens K; Mariën J; Langlois X; Andrés JI; Schmidt M; Macdonald G; Moechars D; Vanduffel W; Tousseyn T; Vandenberghe R; Van Laere K; Verbruggen A; Bormans G
J Nucl Med; 2017 Jun; 58(6):975-981. PubMed ID: 28232614
[TBL] [Abstract][Full Text] [Related]
2. Comparison of New Tau PET-Tracer Candidates With [18F]T808 and [18F]T807.
Declercq L; Celen S; Lecina J; Ahamed M; Tousseyn T; Moechars D; Alcazar J; Ariza M; Fierens K; Bottelbergs A; Mariën J; Vandenberghe R; Andres IJ; Van Laere K; Verbruggen A; Bormans G
Mol Imaging; 2016; 15():. PubMed ID: 27030397
[TBL] [Abstract][Full Text] [Related]
3. [
Sanabria Bohórquez S; Marik J; Ogasawara A; Tinianow JN; Gill HS; Barret O; Tamagnan G; Alagille D; Ayalon G; Manser P; Bengtsson T; Ward M; Williams SP; Kerchner GA; Seibyl JP; Marek K; Weimer RM
Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2077-2089. PubMed ID: 31254035
[TBL] [Abstract][Full Text] [Related]
4. PET Imaging Evaluation of Four σ
Baum E; Cai Z; Bois F; Holden D; Lin SF; Lara-Jaime T; Kapinos M; Chen Y; Deuther-Conrad W; Fischer S; Dukic-Stefanovic S; Bunse P; Wünsch B; Brust P; Jia H; Huang Y
J Nucl Med; 2017 Jun; 58(6):982-988. PubMed ID: 28232607
[TBL] [Abstract][Full Text] [Related]
5. Preclinical Evaluation of a P2X7 Receptor-Selective Radiotracer: PET Studies in a Rat Model with Local Overexpression of the Human P2X7 Receptor and in Nonhuman Primates.
Ory D; Celen S; Gijsbers R; Van Den Haute C; Postnov A; Koole M; Vandeputte C; Andrés JI; Alcazar J; De Angelis M; Langlois X; Bhattacharya A; Schmidt M; Letavic MA; Vanduffel W; Van Laere K; Verbruggen A; Debyser Z; Bormans G
J Nucl Med; 2016 Sep; 57(9):1436-41. PubMed ID: 27199364
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic Evaluation of the Tau PET Radiotracer
Wooten DW; Guehl NJ; Verwer EE; Shoup TM; Yokell DL; Zubcevik N; Vasdev N; Zafonte RD; Johnson KA; El Fakhri G; Normandin MD
J Nucl Med; 2017 Mar; 58(3):484-491. PubMed ID: 27660144
[No Abstract] [Full Text] [Related]
7. Preclinical Evaluation and Quantification of
Khanapur S; van Waarde A; Dierckx RA; Elsinga PH; Koole MJ
J Nucl Med; 2017 Mar; 58(3):466-472. PubMed ID: 27789720
[TBL] [Abstract][Full Text] [Related]
8. Discovery and preclinical characterization of [
Kroth H; Oden F; Molette J; Schieferstein H; Capotosti F; Mueller A; Berndt M; Schmitt-Willich H; Darmency V; Gabellieri E; Boudou C; Juergens T; Varisco Y; Vokali E; Hickman DT; Tamagnan G; Pfeifer A; Dinkelborg L; Muhs A; Stephens A
Eur J Nucl Med Mol Imaging; 2019 Sep; 46(10):2178-2189. PubMed ID: 31264169
[TBL] [Abstract][Full Text] [Related]
9. Preclinical evaluation of 18F-JNJ41510417 as a radioligand for PET imaging of phosphodiesterase-10A in the brain.
Celen S; Koole M; De Angelis M; Sannen I; Chitneni SK; Alcazar J; Dedeurwaerdere S; Moechars D; Schmidt M; Verbruggen A; Langlois X; Van Laere K; Andrés JI; Bormans G
J Nucl Med; 2010 Oct; 51(10):1584-91. PubMed ID: 20847170
[TBL] [Abstract][Full Text] [Related]
10. Preclinical evaluation of [(18)F]JNJ42259152 as a PET tracer for PDE10A.
Celen S; Koole M; Ooms M; De Angelis M; Sannen I; Cornelis J; Alcazar J; Schmidt M; Verbruggen A; Langlois X; Van Laere K; Andrés JI; Bormans G
Neuroimage; 2013 Nov; 82():13-22. PubMed ID: 23664955
[TBL] [Abstract][Full Text] [Related]
11. Monoamine oxidase B inhibitor, selegiline, reduces
Ng KP; Pascoal TA; Mathotaarachchi S; Therriault J; Kang MS; Shin M; Guiot MC; Guo Q; Harada R; Comley RA; Massarweh G; Soucy JP; Okamura N; Gauthier S; Rosa-Neto P
Alzheimers Res Ther; 2017 Mar; 9(1):25. PubMed ID: 28359327
[TBL] [Abstract][Full Text] [Related]
12. Preclinical Characterization of 18F-MK-6240, a Promising PET Tracer for In Vivo Quantification of Human Neurofibrillary Tangles.
Hostetler ED; Walji AM; Zeng Z; Miller P; Bennacef I; Salinas C; Connolly B; Gantert L; Haley H; Holahan M; Purcell M; Riffel K; Lohith TG; Coleman P; Soriano A; Ogawa A; Xu S; Zhang X; Joshi E; Della Rocca J; Hesk D; Schenk DJ; Evelhoch JL
J Nucl Med; 2016 Oct; 57(10):1599-1606. PubMed ID: 27230925
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, characterization, and monkey positron emission tomography (PET) studies of [18F]Y1-973, a PET tracer for the neuropeptide Y Y1 receptor.
Hostetler ED; Sanabria-Bohórquez S; Fan H; Zeng Z; Gantert L; Williams M; Miller P; O'Malley S; Kameda M; Ando M; Sato N; Ozaki S; Tokita S; Ohta H; Williams D; Sur C; Cook JJ; Burns HD; Hargreaves R
Neuroimage; 2011 Feb; 54(4):2635-42. PubMed ID: 21078401
[TBL] [Abstract][Full Text] [Related]
14. [(18)F]T807, a novel tau positron emission tomography imaging agent for Alzheimer's disease.
Xia CF; Arteaga J; Chen G; Gangadharmath U; Gomez LF; Kasi D; Lam C; Liang Q; Liu C; Mocharla VP; Mu F; Sinha A; Su H; Szardenings AK; Walsh JC; Wang E; Yu C; Zhang W; Zhao T; Kolb HC
Alzheimers Dement; 2013 Nov; 9(6):666-76. PubMed ID: 23411393
[TBL] [Abstract][Full Text] [Related]
15. [18F]Fluoroazabenzoxazoles as potential amyloid plaque PET tracers: synthesis and in vivo evaluation in rhesus monkey.
Hostetler ED; Sanabria-Bohórquez S; Fan H; Zeng Z; Gammage L; Miller P; O'Malley S; Connolly B; Mulhearn J; Harrison ST; Wolkenberg SE; Barrow JC; Williams DL; Hargreaves RJ; Sur C; Cook JJ
Nucl Med Biol; 2011 Nov; 38(8):1193-203. PubMed ID: 21741254
[TBL] [Abstract][Full Text] [Related]
16. Preclinical Evaluation of 18F-PF-05270430, a Novel PET Radioligand for the Phosphodiesterase 2A Enzyme.
Chen L; Nabulsi N; Naganawa M; Zasadny K; Skaddan MB; Zhang L; Najafzadeh S; Lin SF; Helal CJ; Boyden TL; Chang C; Ropchan J; Carson RE; Villalobos A; Huang Y
J Nucl Med; 2016 Sep; 57(9):1448-53. PubMed ID: 27199356
[TBL] [Abstract][Full Text] [Related]
17. Discovery of 2-(4-(2-fluoroethoxy)piperidin-1-yl)-9-methyl-9H-pyrrolo[2,3-b:4,5-c']dipyridine ([18F]PI-2014) as PET tracer for the detection of pathological aggregated tau in Alzheimer's disease and other tauopathies.
Gabellieri E; Capotosti F; Molette J; Sreenivasachary N; Mueller A; Berndt M; Schieferstein H; Juergens T; Varisco Y; Oden F; Schmitt-Willich H; Hickman D; Dinkelborg L; Stephens A; Pfeifer A; Kroth H
Eur J Med Chem; 2020 Oct; 204():112615. PubMed ID: 32771872
[TBL] [Abstract][Full Text] [Related]
18. Preclinical and clinical study on [
Xu M; Guo J; Gu J; Zhang L; Liu Z; Ding L; Fu H; Ma Y; Liang S; Wang H
Eur J Nucl Med Mol Imaging; 2022 Jan; 49(2):652-663. PubMed ID: 34292345
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of two 18F-labeled 6-iodo-2-(4'-N,N-dimethylamino)phenylimidazo[1,2-a]pyridine derivatives as prospective radioligands for beta-amyloid in Alzheimer's disease.
Cai L; Chin FT; Pike VW; Toyama H; Liow JS; Zoghbi SS; Modell K; Briard E; Shetty HU; Sinclair K; Donohue S; Tipre D; Kung MP; Dagostin C; Widdowson DA; Green M; Gao W; Herman MM; Ichise M; Innis RB
J Med Chem; 2004 Apr; 47(9):2208-18. PubMed ID: 15084119
[TBL] [Abstract][Full Text] [Related]
20. Preclinical characterization of a novel class of 18F-labeled PET tracers for amyloid-β.
Brockschnieder D; Schmitt-Willich H; Heinrich T; Varrone A; Gulyás B; Toth M; Andersson J; Boemer U; Krause S; Friebe M; Dinkelborg L; Halldin C; Dyrks T
J Nucl Med; 2012 Nov; 53(11):1794-801. PubMed ID: 23008501
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
